Inventor · disambiguated record
Powei Lin
Also filed as: LIN POWEI
10 granted patents·1 pending application·69 citations·filing 2014–2020
87Inventor score
Top patents by PatentIndex Score
11 records- 0196US9505843B2Anti-Her3 scFV fragment and bispecific anti-c-Met/anti-Her3 antibodies comprising the sameSAMSUNG ELECTRONICS CO LTD·Filed 2014·Granted Nov 29, 2016·40 cites·18 claims
- 0289US9730926B2Combination therapy using bispecific anti-c-Met/anti-EGFR antibody and c-Src inhibitorSAMSUNG ELECTRONICS CO LTD·Filed 2015·Granted Aug 15, 2017·6 cites·10 claims
- 0387US10000569B2Anti-cMet/anti-EGFR/anti-HER3 multispecific antibodies and use thereofSAMSUNG ELECTRONICS CO LTD·Filed 2015·Granted Jun 19, 2018·4 cites·4 claims
- 0484US9975960B2Anti-HER2 antibody and anti-c-Met/anti-HER2 bispecific antibodies comprising the sameSAMSUNG ELECTRONICS CO LTD·Filed 2015·Granted May 22, 2018·4 cites·18 claims
- 0584US9902776B2Anti-EGFR antibody and anti-c-Met/anti-EGFR bispecific antibodies comprising the sameSAMSUNG ELECTRONICS CO LTD·Filed 2014·Granted Feb 27, 2018·4 cites·13 claims
- 0682US10143749B2Bispecific anti-Cmet/anti-Her2 antibodiesSAMSUNG ELECTRONICS CO LTD·Filed 2014·Granted Dec 4, 2018·4 cites·10 claims
- 0780US9657104B2Anti-c-Met/anti-EGFR bispecific antibodiesSAMSUNG ELECTRONICS CO LTD·Filed 2014·Granted May 23, 2017·5 cites·9 claims
- 0875US9359440B2Bispecific chimeric proteins comprising DARPinsSAMSUNG ELECTRONICS CO LTD·Filed 2014·Granted Jun 7, 2016·2 cites·18 claims
- 0952US2023192893A1Human genome-derived polynucleotide and method for producing polypeptide of interest using sameSAMSUNG BIOEPIS CO LTD·Filed 2020·Application pending·0 cites
- 1048US9499622B2Anti-EGFR/anti-HER2 bispecific antibodies with anti-EGFR DARPinsSAMSUNG ELECTRONICS CO LTD·Filed 2015·Granted Nov 22, 2016·0 cites·19 claims
- 1138US9943596B2Combination therapy using dual inhibitor of c-MET and EGFR and IGF-1R inhibitorSAMSUNG ELECTRONICS CO LTD·Filed 2015·Granted Apr 17, 2018·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →